COX-2 and MMP-2 Gene SNPs and Colorectal Cancer Susceptibility in the Saudi Population
Asian Pac J Cancer Prev, 15 (12), 4989-4994
Introduction
Colorectal cancer (CRC) is one of the major causes of mortality worldwide. It is ranked the third most common form of cancer worldwide in terms of incidence %URZQ DQG 'X%RLV ZLWK XQDQLPRXV ÀQGLQJV
WKDWSURVWDJODQGLQVDUHLPSRUWDQWIRUERWKFDUFLQRJHQHVLV
DQG SURJUHVVLRQ *UHHQKRXJK HW DO *XVWDIVVRQ
HWDODE Clinical and experimental studies UHSRUWHGWKDW&\FORR[\JHQDVHLQKLELWLRQDWWHQXDWHV
DSSHDUDQFH RI HSLWKHOLDO FDQFHU 5XXG HW DO
:KLOH LQGXFHG SURVWDJODQGLQ SURGXFWLRQ SDUWLFXODUO\
3*(LVNQRZQWREHLQYROYHGLQFHOOVLJQDOLQJWKURXJK
SURVWDQRLG UHFHSWRUV RWKHU REVHUYDWLRQV VXJJHVWHG
VXEW\SH(3UHFHSWRUH[SUHVVLRQLQFRORQFDQFHUWLVVXH
WR SUHGLFW UHGXFHG VXUYLYDO *XVWDIVVRQ HW DO D
1*HQHWLF(QJLQHHULQJDQG%LRWHFKQRORJ\5HVHDUFK,QVWLWXWH*(%5,&LW\IRU6FLHQWLÀF5HVHDUFKDQG7HFKQRORJ\$SSOLFDWLRQV
2'HSDUWPHQWRI0HGLFDO%LRFKHPLVWU\)DFXOW\RI0HGLFLQH5,QVWLWXWHRI*UDGXDWH6WXGLHVDQG5HVHDUFK'HSDUWPHQWRI%LRVFLHQFH
DQG7HFKQRORJ\$OH[DQGULD8QLYHUVLW\$OH[DQGULD(J\SW3'HSDUWPHQWRI%LRFKHPLVWU\&ROOHJHRI6FLHQFH4'HSDUWPHQWRI,QWHUQDO
0HGLFLQH'LYLVLRQRI*DVWURHQWHURORJ\.LQJ.KDOLG8QLYHUVLW\+RVSLWDO.LQJ6DXG8QLYHUVLW\5L\DGK.6$ )RUFRUUHVSRQGHQFH
KHVKDP#KRWPDLOFRPKVDHHG#NVXHGXVD
Abstract
Background: It has been reported that COX-2 expression is associated with MMP-2 expression in thyroid and breast cancers, suggesting that MMPs are linked to COX-2-mediated carcinogenesis. Several polymorphisms within the MMP2 promoter region have been reported in cases with oncogenesis and tumor progression, especially in colorectal carcinogenesis. Materials and Methods: This research evaluated risk of association of the SNPs, including genes for COX-2 (A/G transition at +202) and MMP-2 (C/T transition at-1306), with colorectal cancer in 125 patients and 125 healthy controls. Results and Conclusions:2XUGDWDFRQÀUPHGWKDWMMP2 C-1306 7PXWDWLRQVZHUHVLJQLÀFDQWO\PRUHFRPPRQLQFRORQFDQFHUSDWLHQWVWKDQLQRXUFRQWURO6DXGLSRSXODWLRQ
S 2QWKHRWKHUKDQGLQRXUVWXG\WKHUHZDVQRVLJQLÀFDQWDVVRFLDWLRQEHWZHHQJHQRW\SHGLVWULEXWLRQ
of the COX2SRO\PRUSKLVPDQGFRORUHFWDOFDQFHUS $QHOHYDWHGIUHTXHQF\RIWKHPXWDWHGJHQRW\SHLQ
the control group as compared to the patients subjects indeed suggested that this polymorphism could decrease ULVNLQWKH6DXGLSRSXODWLRQ2XUVWXG\FRQÀUPHGWKDWWKHSRO\PRUSKLVPVWKDWFRXOGDIIHFWWKHH[SUHVVLRQVRI
003DQG&2;WKHFRORQFDQFHUSDWLHQWVZHUHVLJQLÀFDQWO\KLJKHUWKDQWKDWLQWKH&2;QHJDWLYHJURXS
7KHIUHTXHQF\RILQGLYLGXDOVZLWKMMP2 polymorphisms in colon cancer patients was higher than individuals with combination of COX2 and MMP2SRO\PRUSKLVPV2XUVWXG\FRQÀUPHGWKDWLQGLYLGXDOVZKRFDUULHGWKH
polymorphisms that could affect the expressions of COX2 are more susceptible to colon cancer. MMP2 regulatory SRO\PRUSKLVPVFRXOGEHFRQVLGHUHGDVSURWHFWLYHIXUWKHUVWXGLHVQHHGWRFRQÀUPWKHUHVXOWVZLWKPRUHVDPSOHV
and healthy subjects.
Keywords: &RORUHFWDOFDQFHUVLQJOHQXFOHRWLGHSRO\PRUSKLVPPDWUL[PHWDOORSURWHLQDVHF\FORR[\JHQDVH
5(6($5&+$57,&/(
Associations between Single Nucleotide Polymorphisms of COX-2 and MMP-2 Genes and Colorectal Cancer Susceptibility in the Saudi Population
Manal Ali Shalaby
1, Howaida Attia Nounou
2, Mohammad Saud Alanazi
3, Othman Alharby
4, Nahla Azzam
4, Hesham Mahmoud Saeed
5*
*HQHH[SUHVVLRQVWXGLHVLQFRORQFDQFHUVKRZHGWKDWWKH
DSSHDUDQFHDQGSURJUHVVLRQRIFRORUHFWDOFDQFHUVHHPV
WREHUHODWHGWRLQFUHDVHGSURGXFWLRQRI3*(VHFRQGDU\
to COX-2LQGXFWLRQ+XOOHWDO*XVWDIVVRQHWDO
D&DKOLQHWDO5XXGHWDO
,QDQRULJLQDOREVHUYDWLRQDOVWXG\&KDQHWDO REVHUYHGWKDWDVSLULQ·VSUHYHQWLYHUROHZDVHIIHFWLYHRQO\
LQWKHVXEJURXSRIFRORQFDQFHUVRYHUH[SUHVVLQJCOX-2 DPHPEHURIWKHFR[IDPLO\RIHQ]\PHVLQDGRVHDQG
WUHDWPHQWGXUDWLRQGHSHQGHQWPDQQHU7KH&2;IDPLO\
FRQVLVWV RI WZR LVR]\PHV &2;DQG COX-2. While
&2; LV FRQVWLWXWLYHO\ H[SUHVVHG LQ D ZLGH UDQJH RI
RUJDQVDQGUHVSRQVLEOHIRUWLVVXHKRPHRVWDVLVCOX-2 is LQGXFHGXQGHULQÁDPPDWRU\DQGWXPRUSURPRWLRQVWLPXOL
EHLQJRYHUH[SUHVVHGLQDSSUR[LPDWHO\RIDGHQRPDV
DQG RI FRORQ DGHQRFDUFLQRPDV (EHUKDUW HW DO
$QLPDOVWXGLHVKDYHVKRZQWKDWSKDUPDFRORJLFDO
LQKLELWLRQRUJHQHWLFGHOHWLRQRICOX-2 leads to reduced WXPRXU IRUPDWLRQ LQ WKH URGHQW JDVWURLQWHVWLQDO WUDFW
2VKLPDHWDO&KXODGDHWDO7KLHOHWDO
&KXQDQG6XUKZKHUHDVH[SUHVVLRQRICOX-2 GLUHFWO\LQGXFHVWXPRXUJURZWK2VKLPDHWDO
,GHQWLILFDWLRQ RI LQGLYLGXDOV ZKR H[SUHVV KLJKHU
OHYHOV RI COX-2 WKURXJK WKH LQWHUDFWLRQ EHWZHHQ WKH
JHQHWLF EDFNJURXQG DQG HQYLURQPHQWDO H[SRVXUH FRXOG
EH XVHIXO IRU SHUVRQDOL]HG WUHDWPHQW 0DUNRZLW]
7KH LQYROYHPHQW RI COX-2 JHQHWLF YDULDWLRQV
LQ FRORUHFWDO WXPRU GHYHORSPHQW KDV EHHQ SURSRVHG
LQ PDQ\ UHSRUWV 3HUHLUD HW DO 7KH$!*
UV DQG*!& UV SRO\PRUSKLVPV
LGHQWLÀHG LQ JHQH·V SURPRWHU UHJLRQ DUH H[SHFWHG WR
modulate COX-2H[SUHVVLRQE\DOWHULQJWKHUHFRJQLWLRQ
ELQGLQJVLWHIRUVSHFLÀFQXFOHDUSURWHLQVWKXVLQÁXHQFLQJ
WKH JHQHWLF VXVFHSWLELOLW\ IRU &5& RQVHW 3DSDILOL HW
DO =KDQJHWDO,QFRQWUDVWWKH7!&
UV SRO\PRUSKLVP LQ DQ$8ULFK HOHPHQWV UHJLRQ
875 PLJKW FRQWULEXWH WR FDQFHU GHYHORSPHQW E\
LQÁXHQFLQJCOX-2P51$VWDELOLW\&DPSDHWDO
/DQJVHQOHKQHU HWDO6RQJHWDO
003V DUH ODUJH IDPLO\ RI ]LQFGHSHQGHQW
HQGRSHSWLGDVHV VHFUHWHG DV ODWHQW SURHQ]\PHV E\ ERWK
VWURPDO DQG FDQFHU FHOOV :DQJ HW DO 7KH\ DUH
DFWLYDWHGE\SURWHRO\WLFUHPRYDORIDQ1WHUPLQDOGRPDLQ
DQG IXQFWLRQ LQ WKH GHJUDGDWLRQ RI HFWUDFHOOXODU PDWUL[
SURWHLQV WKDW FRQVWLWXWHV FRQQHFWLYH WLVVXHV 7KH\ FDQ
EH FODVVLÀHG LQWR IRXU JURXSV RQ WKH EDVLV RI VHTXHQFH
KRPRORJ\ DQG VXEVWUDWH VSHFLILFLW\ FROODJHQDVHV
JHODWLQDVHV >LQFOXGLQJ JHODWLQDVH $ 003) and JHODWLQDVH%003@VWURPHO\VLQVDQGPHPEUDQHW\SH
PHWDOORSURWHLQDVHV:DVWVRQ6$HWDO:DVWVRQ6$
HWDO 7KHRYHUH[SUHVVLRQRI003VLVNQRZQWREH
DVVRFLDWHGZLWKWXPRULQYDVLRQPHWDVWDVLVDQGDZRUVH
SURJQRVLV.HVVHQEURFNHWDO
6HYHUDOSRO\PRUSKLVPVZLWKLQWKH003SURPRWHU
UHJLRQVKDYHEHHQUHSRUWHGLQFDVHVZLWKRQFRJHQHVLVDQG
WXPRUSURJUHVVLRQHVSHFLDOO\LQFRORUHFWDOFDUFLQRJHQHVLV
'HFRFNHWDO,QKLELWLRQRI003VSURYLGHVRQH
DWWUDFWLYH WDUJHW IRU D QRYHO FODVV RI WKHUDSHXWLF DJHQWV
WR FRQWURO WXPRU SURJUHVVLRQ DQG PHWDVWDWLF VSUHDGLQJ
:DVWVRQHWDO=HUYRVHWDO
,W KDV EHHQ UHSRUWHG WKDW COX-2 expression is associated with 003H[SUHVVLRQLQWK\URLGDQGEUHDVW
FDQFHUV VXJJHVWLQJ WKDW 003V DUH OLQNHG WR COX-2- PHGLDWHGFDUFLQRJHQHVLV6LLURQHQHWDO6LYXODHW
DO$OOWKHGRZQVWUHDPFHOOXODUHIIHFWVRICOX-2 DUHQRW\HWHVWDEOLVKHGCOX-2GHULYHGSURVWDQRLGVPD\
KRZHYHULQGXFHSURGXFWLRQRI003VLQWLVVXHFXOWXUH
H[SHULPHQWV&DOOHMDVHWDO
COX-2 LQKLELWRUV PD\ UHGXFH V\QWKHVLV RI DFWLYH
003V,QDGGLWLRQLQKLELWLRQRICOX-2 causes reduction in pro-003H[SUHVVLRQLQRYDULDQFDUFLQRPDFHOOVDQG
003H[SUHVVLRQLVUHGXFHGLQJDVWULFFDQFHUFHOOVE\
WKHEORFNLQJRICOX-2&KXUFKHWDO6\PRZLF]
HWDO:XHWDO
7KLVUHVHDUFKZLOOLQYHVWLJDWHWKHULVNRIDVVRFLDWLRQ
RIWKH613VLQFOXGLQJJHQHVIRUCOX-2$*WUDQVLWLRQ
at +202) and 003 &7 WUDQVLWLRQ DW ZLWK
FRORUHFWDO FDQFHU LQ FRORUHFWDO FDQFHU SDWLHQWV DQG
KHDOWK\FRQWUROV
Materials and Methods
&KHPLFDOV
$OO FKHPLFDOV XVHG ZHUH RI DQDO\WLFDO UHDJHQW
PROHFXODU ELRORJ\ RU FKURPDWRJUDSKLF JUDGH DV
DSSURSULDWH:DWHUZDVGHLRQL]HGDQGGLVWLOOHG
6DPSOHVFROOHFWLRQ
7KLVVWXG\ZDVFRQGXFWHGDIWHUUHYLHZDQGDSSURYDORI
WKH,QVWLWXWLRQDO5HYLHZ%RDUGRIWKH(WKLFV&RPPLWWHH
DW.LQJ.KDOLG8QLYHUVLW\+RVSLWDOLQ5L\DGK.LQJGRP
RI6DXGL$UDELD%ORRGVDPSOHVZHUHFROOHFWHGIURP
FRQÀUPHGFRORQFDQFHUSDWLHQWVDJHUDQJH\HDUV
PHDQDJH\HDUVDQGDJHPDWFKHGKHDOWK\FRQWUROV
7KHGLDJQRVLVRIFDQFHUZDVEDVHGRQVWDQGDUGFOLQLFDO
HQGRVFRSLFUDGLRORJLFDODQGKLVWRORJLFDOFULWHULD&OLQLFDO
DQGGHPRJUDSKLFFKDUDFWHULVWLFVZHUHUHFRUGHGLQFOXGLQJ
DJHDWGLDJQRVLVHVWURJHQUHFHSWRUSURJHVWHURQHUHFHSWRU
+(5 VWDWXV IDPLO\ KLVWRU\ VPRNLQJ KDELWV GLVHDVH
EHKDYLRUGLVHDVHORFDWLRQDQGQHHGIRUVXUJHU\
*HQRPLF'1$LVRODWLRQDQGSXULÀFDWLRQ
*HQRPLF'1$ZDVLVRODWHGIURPZKROHEORRGVDPSOHV
XVLQJ'1HDV\%ORRGNLW4LDJHQZKHUHVDPSOHVZHUHÀUVW
O\VHGWKHQWKHO\VDWHZDVORDGHGRQWRWKH'1HDV\0LQL
VSLQFROXPQ&RQFHQWUDWLRQVDQGSXULW\RI'1$VDPSOHV
ZHUHDVVHVVHGXVLQJ1DQR'URS7KHUPR6FLHQWLÀF
*HQRW\SLQJIRU003 and COX-2
*HQRW\SLQJ IRU WKH & 7 UV LQ WKH
·IODQNLQJ UHJLRQ RI 003 JHQH /DFFKLQL et al.,
ZDV SHUIRUPHG E\ UHDO WLPH SRO\PHUDVH FKDLQ
UHDFWLRQ573&5XVLQJ7DT0DQ$OOHOH'LVFULPLQDWLRQ
DVVD\ $SSOLHG %LRV\VWHPV &DUOVEDG &$ 86$
3UREHV DQG SULPHUV XVHG IRU WKH &7 JHQRW\SLQJ
DVVD\ ZHUH FXVWRPL]HG DV IROORZV IRUZDUG ·
*&&$77*7&$$7*77&&&7$$$$&$· UHYHUVH
·7*$&77&7*$*&7*$*$&&7*$$
· DQG SUREHV ·&$*&$&7& >7&@$&&7&7·
*HQRW\SLQJIRUCOX-2WKH$*UVLQWKH
·ÁDQNLQJUHJLRQRICOX-2JHQH2]KDQHWDOZDV
SHUIRUPHGE\UHDOWLPHSRO\PHUDVHFKDLQUHDFWLRQ573&5 XVLQJ 7DT0DQ$OOHOH 'LVFULPLQDWLRQ DVVD\ $SSOLHG
%LRV\VWHPV&DUOVEDG&$86$3UREHVDQGSULPHUVXVHG
IRUWKH$*JHQRW\SLQJDVVD\ZHUHFXVWRPL]HGDV
IROORZVIRUZDUG·&&&7$777$**$**7*$*$*·
UHYHUVH·7&$*&&$7$&$**7*$*7$&·DQGSUREHV
·$$&$*$$$$7&7*$*$$$$&$7$7& >$*@
77$77&$$*&$&$*&77**7$&77&·
7DT0DQ3&5ZDVSHUIRUPHGLQDWRWDOYROXPHRIƫO
FRQWDLQLQJQJRIJHQRPLF'1$[7DT0DQPDVWHUPL[
DQG[DVVD\PL[SODFHGLQZHOO3&5SODWH7KH3&5
FRQGLWLRQVZHUHF\FOHDW&IRUPLQIROORZHGE\
F\FOHVDW&IRUVHFRQGV&IRUVHFRQGVDQG
&IRUPLQ7KHÀQDOH[WHQVLRQVWHSZDVFDUULHGRXWDW
&IRUPLQ)OXRUHVFHQFHIURP3&5DPSOLÀFDWLRQZDV
GHWHFWHGXVLQJ&KURPRGHWHFWRU$SSOLHG%LRV\VWHPV
)DVW5HDO7LPH3&56\VWHPDQGDQDO\]HGZLWKWKH
PDQXIDFWXUHU·VVRIWZDUH
COX-2 and MMP-2 Gene SNPs and Colorectal Cancer Susceptibility in the Saudi Population
7DT0DQ5HDO7LPH3&5DVVD\LVEDVHG7DT0DQSUREHV
FRQVLVWRIDÁXRURSKRUHFRYDOHQWO\DWWDFKHGWRWKH·HQG
RIWKHROLJRQXFOHRWLGHSUREHDQGDTXHQFKHUDWWKH·HQG
7DT0DQSUREHVDUHGHVLJQHGVXFKWKDWWKH\DQQHDOZLWKLQD
'1$UHJLRQDPSOLÀHGE\DVSHFLÀFVHWRISULPHUV7KH7DT
SRO\PHUDVHH[WHQGVWKHSULPHUDQGV\QWKHVL]HVWKHQDVFHQW
VWUDQGWKH·WR·H[RQXFOHDVHDFWLYLW\RIWKHSRO\PHUDVH
GHJUDGHV WKH SUREH WKDW KDV DQQHDOHG WR WKH WHPSODWH
'HJUDGDWLRQRIWKHSUREHUHOHDVHVWKHÁXRURSKRUHIURP
LW DQG EUHDNV WKH FORVH SUR[LPLW\ WR WKH TXHQFKHU WKXV
UHOLHYLQJWKHTXHQFKLQJHIIHFWDQGDOORZLQJÁXRUHVFHQFH
RIWKHÁXRURSKRUH+HQFHÁXRUHVFHQFHGHWHFWHGLQWKH
real-time PCR thermal cycler is directly proportional to WKHÁXRURSKRUHUHOHDVHGDQGWKHDPRXQWRI'1$WHPSODWH
present in the PCR.
PCR sequencing
3URGXFWV VHTXHQFLQJ ZDV FDUULHG RXW DFFRUGLQJ WR
6DQJHUHWDOXVLQJWKH0HJD%$&(
'1$6HTXHQFLQJ6\VWHP3KDUPDFLD$PHUVKDP
&R 7KH FKDLQ WHUPLQDWLRQ VHTXHQFLQJ UHDFWLRQ ZDV
FRQGXFWHG XWLOL]LQJ WKH '<(QDPLF (7 WHUPLQDWRU
NLW DV DQ LQWHJUDO SDUW RI WKH 0HJD%$&( '1$
VHTXHQFLQJ V\VWHP '1$ WHPSODWH XQODEHOHG SULPHU
EXIIHU WKH IRXU G173V WKH IRXU ÁXRUHVFHQWO\ ODEHOHG
GG173VDQG$PSOL7DT'1$3RO\PHUDVHDUHDGGHGWR
WKH UHDFWLRQ WXEH )OXRUHVFHQW IUDJPHQWV DUH JHQHUDWHG
E\LQFRUSRUDWLRQRIG\HODEHOHGGG173V(DFKGLIIHUHQW
GG173GG$73GG&73GG*73RUGG773ZLOOFDUU\D
GLIIHUHQW FRORU RI G\H$OO WHUPLQDWHG IUDJPHQWV WKRVH
HQGLQJZLWKDGG173 WKHUHIRUHZLOOFRQWDLQD G\HDW
WKHLU · HQG %LJ'\H WHUPLQDWRUV XWLOL]H VLQJOH HQHUJ\
WUDQVIHUPROHFXOHVZKLFKLQFOXGHDQHQHUJ\GRQRUDQG
DFFHSWRU G\H FRQQHFWHG E\ D KLJKO\ HIILFLHQW HQHUJ\
WUDQVIHUOLQNHU,QWKHVWUXFWXUHRIWKH%LJ'\HPROHFXOH
WKHDFFHSWRULVDGLFKORURUKRGDPLQHG\H7KHVHEULJKWHU
FOHDQHU G\HV UHVXOW LQ D VHTXHQFLQJ FKHPLVWU\ VXL7DEOH
IRUPRVWDSSOLFDWLRQV7KHVHTXHQFLQJUHDFWLRQSURGXFWV
ZHUHSXULÀHGXVLQJ'\H([6SLQ.LW4LDJHQ DQGDSSOLHGWR0HJD%DFH6HTXHQFLQJPDFKLQH
Statistical analysis
)LVKHU·VH[DFWWHVWDQGWKHRGGVUDWLR2'ZLWK
FRQÀGHQFHLQWHUYDO&,ZHUHXVHGWRWHVWWKHDVVRFLDWLRQ
EHWZHHQFDQFHUDQGWKHVWXGLHGJHQHWLFSRO\PRUSKLVPV
DQG WR GHVFULEH WKH VWUHQJWK RI WKH DVVRFLDWLRQ 7KH
DVVRFLDWLRQVZHUHFRQVLGHUHGWREHVWDWLVWLFDOO\VLJQLÀFDQW
LIWKH)LVKHU·VH[DFWSYDOXHZDVOHVVWKDQDQGLIWKH
&,H[FOXGHGWKHYDOXH$OOVWDWLVWLFDOFDOFXODWLRQV
ZHUHGRQHXVLQJ0HG&DOF6RIWZDUH9HUVLRQ
0HG&DOF6RIWZDUHEYED
Results
,W VKRXOG EH QRWHG WKDW WKH PROHFXODU WRROV XVHG
IRU WKH JHQRW\SLQJ GR QRW GHWHUPLQH ZKHWKHU RWKHU
SRO\PRUSKLVPVLQWKHVDPHJHQHDUHDOVRSUHVHQWLQWKH
WHVWHGVXEMHFW7KHZLOGW\SHZWGHQRWDWLRQWKXVUHIHUV
WRWKHZLOGW\SHDOOHOHDWWKHLQYHVWLJDWHGSRO\PRUSKLFVLWH
RQO\UHJDUGOHVVRIRWKHUXQVWXGLHGSRO\PRUSKLVPVIRUWKDW
SDUWLFXODUJHQH)XUWKHUPRUHLQWKLVVWXG\WKHUHZHUHQR
VLJQLÀFDQWGLIIHUHQFHVLQWKHGLVWULEXWLRQRIJHQRW\SHVIRU
PDOHJURXSVZKHQFRPSDUHGZLWKIHPDOHJURXS
$ WRWDO RI FRORQ FDQFHU FDVHV DQG KHDOWK\
FRQWUROVZHUHLQFOXGHGLQWKLVFDVHFRQWUROEDVHGVWXG\
Clinical characteristics of colon cancer cases and healthy FRQWUROV DUH JLYHQ LQ7DEOH$PRQJ WKH FRORQ FDQFHU
SDWLHQWVPDOHVDQGIHPDOHVZHUHVPRNHUV
DQG KDG WKH FDQFHU LQ WKH FRORQ LQ WKH
rectum.
7KHJHQRW\SHDQGDOOHOHIUHTXHQFLHVRIWKH&7LQ
WKH·ÁDQNLQJUHJLRQRI003JHQHLQ&5&SDWLHQWV
Table 1. Clinical Characteristics of Study Subjects 9DULDEOH &RORUHFWDO +HDOWK\ SYDOXH
cancer controls
$JHJURXS
*HQGHU )HPDOH
0DOH
6PRNLQJVWDWXV 6PRNHU
1RQVPRNHU
7XPRU/RFDWLRQ &RORQ
5HFWXP
Table 2. *HQRW\SH)UHTXHQFLHVRI003*HQH3RO\PRUSKLVPLQ&RORQ&DQFHU&DVHVDQG&RQWUROV
003*HQRW\SH &DVHV &RQWUROV 25 &, Ɲ2 SYDOXH
&&ZLOG 5HI
&7
77YDULDQW
&777
& 5HI
7
Table 3. *HQRW\SLQJ)UHTXHQF\RI&R[*HQH3RO\PRUSKLVPVLQ&RORQ&DQFHU&DVHVDQG&RQWUROV
&R[*HQRW\SLQJ &DVHV &RQWUROV 25 &, Ɲ2 SYDOXH
**ZLOG 5HI
*7
77YDULDQW
*777
* 5HI
7
DQGKHDOWK\FRQWUROVDUHVKRZQLQ7DEOH7KHPXWDQW
JHQRW\SHIUHTXHQFLHVRI003&7LQWKHSDWLHQW
JURXSZHUHFRPSDUHGZLWKIUHTXHQFLHVRILQWKH
FRQWUROJURXS7KHPXWDQWDOOHOHIUHTXHQFLHVRI&7
LQWKHSDWLHQWJURXSZHUHFRPSDUHGZLWKIUHTXHQFLHV
RILQWKHFRQWUROJURXS7KHFRUUHVSRQGLQJ3YDOXHV
DQG2GGUDWLR25DQGFRQÀGHQFHLQWHUYDO^
&,`ZHUHDVIROORZVS 25&,
IRUWKHPXWDQWJHQRW\SH7KH3YDOXHVDQG25
^&,`IRUWKHPXWDQWDOOHOHVZHUHDVIROORZVS
25&,WR7DEOH
7KH PXWDQW JHQRW\SH IUHTXHQFLHV RI &R[ +202
$* LQ WKH SDWLHQW JURXS ZHUH FRPSDUHG ZLWK
IUHTXHQFLHV RI LQ WKH FRQWURO JURXS7KH PXWDQW
DOOHOHIUHTXHQFLHVRI$*LQWKHSDWLHQWJURXSZHUH
FRPSDUHGZLWKIUHTXHQFLHVRILQWKHFRQWURO
JURXS7KHFRUUHVSRQGLQJ3YDOXHVDQG2GGUDWLR25 DQG FRQÀGHQFH LQWHUYDO ^ &,` IRU WKH PXWDQW
JHQRW\SH ZHUH DV IROORZV S 25 &,
7KH3YDOXHVDQG25^&,`IRUWKH
PXWDQWDOOHOHVZHUHDVIROORZVS 25&,
7DEOH7KHIUHTXHQF\RILQGLYLGXDOV
ZLWK 003 SRO\PRUSKLVPV LQ FRORQ FDQFHU
SDWLHQWV ZDV VLJQLÀFDQWO\ KLJKHU WKDQ LQGLYLGXDOV ZLWK
FRPELQDWLRQRI&R[DQG003SRO\PRUSKLVPV 7DEOH
Discussion
,QWKHUHFHQW\HDUVLQWHUHVWLQWKHJHQHWLFVXVFHSWLELOLW\
WRFDQFHUVKDVOHGWRDJURZLQJDWWHQWLRQWRWKHVWXG\RI
SRO\PRUSKLVPVRIJHQHVLQYROYHGLQWXPRXULJHQHVLV
&R[ DQG 003 PXWDWLRQV DUH ZHOONQRZQ FRORQ
FDQFHUVXVFHSWLELOLW\DOOHOHVEXWWKHULVNDVVRFLDWHGZLWK
WKH PXWDWLRQV DW WKH LQGLYLGXDO DQG SRSXODWLRQ OHYHOV
UHPDLQVODUJHO\LQGHWHUPLQDWH7KHGDWDSUHVHQWHGKHUHDQG
SUHYLRXVUHSRUWVGHPRQVWUDWHWKDWLQGLIIHUHQWSRSXODWLRQV
ODUJHYDULDWLRQVDUHREVHUYHGIRUWKHIUHTXHQFLHVRIWKH
common mutations.
2XUGDWDFRQÀUPHGWKDW003&7PXWDWLRQV
are more common in colon cancer patients than in control 6DXGLSRSXODWLRQDGGLWLRQDOJHQHWLFDQGRUHQYLURQPHQWDO
FRIDFWRUV DUH UHTXLUHG IRU GLVHDVH GHYHORSPHQW DW WKH
LQGLYLGXDODQGSRSXODWLRQOHYHOV
Polymorphisms within the 003SURPRWHUUHJLRQV
KDYHEHHQUHSRUWHGLQFDVHVZLWKRQFRJHQHVLVDQGWXPRU
SURJUHVVLRQ HVSHFLDOO\ LQ FRORUHFWDO FDQFHU 'HFRFN HW
DO 3UHYLRXV VWXGLHV VKRZHG WKDW WKH 613 &7
WUDQVLWLRQDWLVUHSRUWHGWRLQWHUUXSWWKH6SW\SH
SURPRWHU VLWH &&$&& ER[ FDXVLQJ ORZHU SURPRWHU
DFWLYLW\DQGDOVRUHGXFLQJWKHWUDQVFULSWLRQDODFWLYLW\;X
HWDO3ULFHHWDOLGHQWLÀHGWKH&7
SRO\PRUSKLVP LQ WKH 003 SURPRWHU DQG VKRZHG D
VWULNLQJO\ORZHUSURPRWHUDFWLYLW\ZLWKWKH7DOOHOHYLD
LQYLWURWUDQVLHQWWUDQVIHFWLRQH[SHULPHQW,WLVOLNHO\WKDW
WKH && JHQRW\SH PD\ EH DVVRFLDWHG ZLWK D KLJK
WUDQVFULSWLRQOHYHODQGHQ]\PHDFWLYLW\RI003, and HYHQWXDOO\ LW PLJKW DIIHFW LQGLYLGXDO VXVFHSWLELOLWLHV WR
neoplasms.
,QFUHDVHG SURVWDQRLG DFWLYLW\ LV D ZHOO UHFRJQL]HG
FKDUDFWHULVWLFRIFRORUHFWDOFDQFHU&DKOLQHWDO+XOO
HWDO:DQJDQG'XERLV$VWLQJHWDO
(NDPEDUDPHWDO=KDRHWDO&RORUHFWDO
FDQFHUGHYHORSPHQWDQGSURJUHVVLRQKDVEHHQDOOLHGWR
WKH LQFUHDVHG SURGXFWLRQ RI 3*( VHFRQGDU\ WR COX- 2LQGXFWLRQLQKRVWVWURPD+XOOHWDO&DKOLQHW
DO$VWLQJHWDO7KHUROHRICOX-2 JHQHLQGXFWLRQLQFRORUHFWDOFDQFHUGLVHDVHUHPDLQWREH
HOXFLGDWHGDOWKRXJKDORWRILQIRUPDWLRQLVDYDLODEOHRQ
WKHUHJXODWLRQRICOX-2JHQHH[SUHVVLRQ&KXQDQG6XUK
7VDWVDQLVHWDO
COX-2 LV DQ LQGXFLEOH HQ]\PH WKDW SHUIRUPV WKH
UDWHOLPLWLQJ VWHS LQ WKH FRQYHUVLRQ RI IUHH DUDFKLGRQLF
DFLGLQWRSURVWDJODQGLQVZKLFKSOD\DGLVWLQFWUROHLQFHOO
SUROLIHUDWLRQDQGDUHSRWHQWPHGLDWRUVRILQÁDPPDWLRQ
6XEVWDQWLDO HYLGHQFH KDV VKRZQ XQUHJXODWHG COX-2 H[SUHVVLRQ WR EH D FRQWULEXWLQJ IDFWRU LQ PDQ\ FKURQLF
GLVHDVHVDQGFDQFHU0HQWHUHWDO
0DQ\JHQHWLFYDULDQWVZLWKLQWKHCOX-2JHQHKDYH
EHHQ LGHQWLÀHG DQG VHOHFW SRO\PRUSKLVPV KDYH VKRZQ
GLVHDVHDVVRFLDWLRQ7KLVVWXG\IRFXVHVRQWKHJHQRW\SH
DQGDOOHOHIUHTXHQFLHVRIWKH$*LQWKH·ÁDQNLQJ
UHJLRQ IRU COX-2 JHQH LQ &5& SDWLHQWV DQG
KHDOWK\FRQWUROVVKRZQLQ7DEOH
,Q RXU VWXG\ WKHUH ZDV QR VLJQLÀFDQW DVVRFLDWLRQ
EHWZHHQJHQRW\SHGLVWULEXWLRQRIWKH&R[ polymorphism DQG FRORUHFWDO FDQFHU 7KH HOHYDWHG IUHTXHQF\ RI WKH
PXWDWHGJHQRW\SHLQWKHFRQWUROJURXSRWKHUWKDQSDWLHQWV·
VXEMHFWV VXJJHVWV WKDW WKLV SRO\PRUSKLVP FRXOG KDYH
D GHFUHDVHG ULVN LQ WKH 6DXGL SRSXODWLRQ 0RUHRYHU
QR VLJQLÀFDQW GLIIHUHQFH ZDV QRWHG LQ FR[$*
SRO\PRUSKLVPDQGFOLQLFRSDWKRORJLFDOSDUDPHWHUV
7KH IXQFWLRQDO LPSDFW RI UV FR[-+202
$* DQ LQWURQLF YDULDQW RQ COX-2 DFWLYLW\ LV QRW \HW
NQRZQ 6HYHUDO VWXGLHV ZHUH FRQGXFWHG WR LQYHVWLJDWH
the associations of COX-2 rs2745557 FR[$*
ZLWKSURVWDWHFDQFHU3&DVXVFHSWLELOLW\:XHWDO
$PLULDQHWDO6DOLQDVHWDO)UDGHWHWDO
'RVVXVHWDO&KHQJHWDO 6KDKHGL et DOCOX-2$*UVSRO\PRUSKLVP
was associated with a trend of PCa risk under dominant PRGHO DQG DOOHOLF PRGHO LQ $IULFDQ $PHULFDQV DQG
$PHULFDQ &DXFDVLDQ PHQ KRZHYHU VLJQLÀFDQW UHODWLRQ
ZDVDEVHQWLQ$VLDQV
7KHUVFR[$*ZDVDVVRFLDWHGZLWK
D ORZHU 3FD ULVN XQGHU GRPLQDQW PRGHO +RZHYHU
WKH VLJQLILFDQW DVVRFLDWLRQ LV FRPSOHWHO\ ORVW XQGHU
KRPRJHQHRXV FRGRPLQDQW PRGHO RU DOOHOLF PRGHO
0HWDQDO\VLVGDWDVXJJHVWWKDWUVPD\DVVRFLDWH
ZLWK D ORZHU 3&D ULVN XQGHU RYHUGRPLQDQW PRGHO
+RZHYHU WKH VLJQLÀFDQW DVVRFLDWLRQ ZDV DEVHQW 7KH
UHDVRQIRUWKLVSKHQRPHQRQPD\EHFDXVHGE\DODFNRI
VXIÀFLHQWJHQRW\SHGDWDLQVHYHUDOVWXGLHV
Table 4. Comparisons between the Two Groups Studied according to Combinations of Mutations
Patients Control 1RQHRIWKHPXWDQWDOOHOHV
&R[2QO\
003RQO\
&R[00S
COX-2 and MMP-2 Gene SNPs and Colorectal Cancer Susceptibility in the Saudi Population 3URVWDJODQGLQ ( KDV EHHQ UHSRUWHG WR UHJXODWH WKH
PHWDVWDWLFSRWHQWLDORIFHOOVWKURXJKUHJXODWLRQRI003
2 0DVIHUUHU HW DO +XD HW DO 7KXV LW LV
SRVVLEOHWKDWCOX-2 expression is associated with 003
H[SUHVVLRQ3UHYLRXVVWXGLHVVXJJHVWWKDWWKHUHLVDGLUHFW
OLQNEHWZHHQCOX-2 and 003 as transfection of COX-2 LQFUHDVHVWKHDPRXQWRIDFWLYDWHG003LQEUHDVWDQG
FRORQFDQFHUFHOOV7VXMLLHWDO
$ GLUHFW OLQN EHWZHHQ COX-2 and 003 has EHHQ VKRZQ WR H[LVW LQ VHYHUDO H[SHULPHQWDO PRGHOV
0DVIHUUHUHWDOKDYHUHSRUWHGWKDWCOX-2 stimulates HQGRWKHOLDO FHOO PLJUDWLRQ DQG YHVVHO WXEH IRUPDWLRQ
DQGWKHVHSURFHVVHVDUHLQKLELWHGE\QRQVWHURLGDODQWL
LQÁDPPDWRU\GUXJV7KH\DOVRUHSRUWHGWKDWCOX-2 affects the 003OHYHOVDQGWKHDFWLYDWHGFROODJHQDVHOHYHOV
7KHSUHVHQWVWXG\IRXQGWKDWWKHH[SUHVVLRQVRI9(*)DQG
003 in the COX-2SRVLWLYHJURXSZHUHVLJQLÀFDQWO\
KLJKHUWKDQWKDWLQWKHCOX-2QHJDWLYHJURXS7VXMLLHW
DO
References
$PLULDQ(6,WWPDQQ006FKHXUHU0($VVRFLDWLRQV
EHWZHHQDUDFKLGRQLFDFLGPHWDEROLVPJHQHSRO\PRUSKLVPV
and prostate cancer risk. Prostate,
$VWLQJ*&DUpQ+$QGHUVVRQ0/|QQURWK&/DJHUVWHGW.
/XQGKROP.COX-2JHQHH[SUHVVLRQLQFRORQFDQFHU
WLVVXHUHODWHGWRUHJXODWLQJIDFWRUVDQGSURPRWHUPHWK\ODWLRQ
status. %0&&DQFHU, 11
Brown JR, DuBois RN (2005). COX-2DPROHFXODUWDUJHWIRU
FRORUHFWDOFDQFHUSUHYHQWLRQJ Clin Oncol, 23, 2840-55.
&DKOLQ&/RQQURWK&$UYLGVVRQ$1RUGJUHQ6/XQGKROP.
*URZWKDVVRFLDWHGSURWHLQVLQWXPRUFHOOVDQGVWURPD
UHODWHGWRGLVHDVHSURJUHVVLRQRIFRORQFDQFHUDFFRXQWLQJIRU
WXPRUWLVVXH3*(FRQWHQWInt J Oncol, 32
&DOOHMDV 1$ &DVDGR 0 'LD]*XHUUD 0 ([SUHVVLRQ
RI F\FORR[\JHQDVH SURPRWHV WKH UHOHDVH RI PDWUL[
metalloproteinase-2 and -9 in fetal rat hepatocytes.
+HSDWRORJ\, 33
&DPSD'=LHQROGGLQ\60DJJLQL9HWDO$VVRFLDWLRQ
RIDFRPPRQSRO\PRUSKLVPLQWKHF\FORR[\JHQDVHJHQH
ZLWK ULVN RI QRQVPDOO FHOO OXQJ FDQFHU Carcinogenesis, 25
&KXQ .6 6XUK < 6LJQDO WUDQVGXFWLRQ SDWKZD\V
UHJXODWLQJF\FORR[\JHQDVHH[SUHVVLRQSRWHQWLDOPROHFXODU
WDUJHWV IRU FKHPRSUHYHQWLRQ %LRFKHP 3KDUPDFRO, 68,
&KXQ66XUK-&DQFHUFKHPRSUHYHQWLRQWDUJHWLQJFR[
XVLQJGLHWDU\SK\WRFKHPLFDOVLQ¶&DQFHUDQG,QÁDPPDWLRQ
0HFKDQLVPV&KHPLFDO%LRORJLFDODQG&OLQLFDO$VSHFWV·
HGV<+LUDNX6.DZDQLVKLDQG+2KVKLPD-RKQ:LOH\
6RQV,QF+RERNHQ1-86$
&KXUFK 5' )OHVKPDQ -: 0F/HRG +/ &\FOR
R[\JHQDVH LQKLELWLRQ LQ FRORUHFWDO FDQFHU WKHUDS\ Br J Surg, 90
&KDQ$72JLQR6)XFKV&6$VSLULQDQGWKHULVNRI
colorectal cancer in relation to the expression of COX-2. 1
(QJO-0HG, 356
&KHQJ , /LX ; 3OXPPHU 6- HW DO &2; JHQHWLF
YDULDWLRQ16$,'VDQGDGYDQFHGSURVWDWHFDQFHUULVN Br J Cancer,
&KXODGD 3& 7KRPSVRQ 0% 0DKOHU -) *HQHWLF
GLVUXSWLRQ RI 3WJV DV ZHOO DV 3WJV UHGXFHV LQWHVWLQDO
WXPRULJHQHVLVLQ0LQPLFHCancer Res, 60, 4705-8.
'HFRFN-3DULGDHQV5<H6*HQHWLFSRO\PRUSKLVPV
RIPDWUL[PHWDOORSURWHLQDVHVLQOXQJEUHDVWDQGFRORUHFWDO
cancer. Clin Genet,
'RVVXV/.DDNV5&DQ]LDQ)HWDO37*6DQG,/
JHQHWLF YDULDWLRQ DQG ULVN RI EUHDVW DQG SURVWDWH FDQFHU
results from the Breast and Prostate Cancer Cohort
&RQVRUWLXP%3&Carcinogenesis, 31
(EHUKDUW&(&RIIH\5-5DGKLND$HWDO8SUHJXODWLRQ
RIF\FORR[\JHQDVHJHQHH[SUHVVLRQLQKXPDQFRORUHFWDO
adenomas and adenocarcinomas. Gastroenterology, ,
(NDPEDUDP3/DPELY:&D]]ROOL5$VKWRQ:+RQQ9
7KHWKURPER[DQHV\QWKDVHDQGUHFHSWRUVLJQDOLQJSDWKZD\
LQFDQFHUDQHPHUJLQJSDUDGLJPLQFDQFHUSURJUHVVLRQDQG
metastasis. &DQFHUDQG0HWDVWDVLV5HYLHZV, 30
)UDGHW9&KHQJ,&DVH\*:LWWH-6'LHWDU\RPHJD
IDWW\ DFLGV F\FORR[\JHQDVH JHQHWLF YDULDWLRQ DQG
DJJUHVVLYHSURVWDWHFDQFHUULVNClin Cancer Res, 15, 2559-
*UHHQKRXJK$6PDUWW+-0RRUH$(HWDO7KHCOX- 23*(SDWKZD\NH\UROHVLQWKHKDOOPDUNVRIFDQFHUDQG
DGDSWDWLRQWRWKHWXPRXUPLFURHQYLURQPHQWCarcinogenesis, 30
*XVWDIVVRQ$ +DQVVRQ ( .UHVVQHU 8 HW DO (3
VXEW\SH &2; DQG 33$5 JDPPD UHFHSWRU H[SUHVVLRQ LQ
FRORUHFWDOFDQFHULQSUHGLFWLRQRIGLVHDVHVSHFLÀFPRUWDOLW\
Int J Cancer, 121
*XVWDIVVRQ$+DQVVRQ(.UHVVQHU8HWDO3URVWDQRLG
receptor expression in colorectal cancer related to tumor VWDJHGLIIHUHQWLDWLRQDQGSURJUHVVLRQActa Oncol, 56
+XOO 0$ .R 6& +DZFURIW * 3URVWDJODQGLQ (3
UHFHSWRUVWDUJHWVIRUWUHDWPHQWDQGSUHYHQWLRQ of colorectal cancer? 0RO&DQFHU7KHU, 3
+XD + /L 0 /XR 7 <LQ < -LDQJ < 0DWUL[
PHWDOORSURWHLQDVHVLQWXPRULJHQHVLVDQHYROYLQJSDUDGLJP
&HOOXODUDQG0ROHFXODU/LIH6FLHQFHV, 68
.HVVHQEURFN.3ODNV9:HUE=0DWUL[PHWDOORSURWHLQDVHV
UHJXODWRUVRIWKHWXPRUPLFURHQYLURQPHQWCell, 141
/DFFKLQL 5 -DFRE)HUUHLUD$/ /XL]RQ 05 HW DO
&RPPRQ PDWUL[ PHWDOORSURWHLQDVH JHQH KDSORW\SHV
PD\PRGXODWHOHIWYHQWULFXODUUHPRGHOOLQJLQK\SHUWHQVLYH
patients. -+XP+\SHUWHQV, 26
/DQJVHQOHKQHU8<D]GDQL%LXNL%(GHU7HWDO7KH
F\FORR[\JHQDVH 37*6 7 !& SRO\PRUSKLVP LV
DVVRFLDWHG ZLWK EUHDVW FDQFHU ULVN Clin Cancer Res, 12,
0DUNRZLW] 6' $VSLULQ DQG FRORQ FDQFHUWDUJHWLQJ
SUHYHQWLRQ"1(QJO-0HG, 356
0DVIHUUHU-//HDK\.0.RNL$7HWDO$QWLDQJLRJHQLF
DQG DQWLWXPRU DFWLYLWLHV RI F\FORR[\JHQDVH LQKLELWRUV
Cancer Res, 60
0HQWHU'*6FKLOVN\5/'X%RLV51&\FORR[\JHQDVH
DQGFDQFHUWUHDWPHQWXQGHUVWDQGLQJWKHULVNVKRXOGEHZRUWK
the reward. Clin Cancer Res, 16
2VKLPD 0 'LQFKXN -( .DUJPDQ 6/ 6XSSUHVVLRQ
RILQWHVWLQDOSRO\SRVLVLQ$SFGHOWDNQRFNRXWPLFHE\
LQKLELWLRQRIF\FORR[\JHQDVHCOX-2). Cell,
2VKLPD + 2VKLPD 0 ,QDED . +\SHUSODVWLF JDVWULF
WXPRXUV LQGXFHG E\ DFWLYDWHG PDFURSKDJHV LQ COX-2
P3*(6WUDQVJHQLFPLFH(0%2-, 23
2]KDQ*/RFKDQ5/HDWKDUW-%6&KDUQOH\5'DO\$.
&\FORR[\JHQDVH SRO\PRUSKLVPV DQG SDQFUHDWLF FDQFHU
VXVFHSWLELOLW\Pancreas, 40
3HUHLUD & 0HGHLURV 50 'LQLV5LEHLUR 0-
&\FORR[\JHQDVH SRO\PRUSKLVPV LQ JDVWULF DQG FRORUHFWDO
FDUFLQRJHQHVLV DUH FRQFOXVLYH UHVXOWV DYDLODEOH" Eur J
*DVWURHQWHURO+HSDWRO, 21
3DSDÀOL$ +LOO 05 %UXOO '- 0F$QXOW\ 5- 0DUVKDOO 53
0 25.0 50.0 75.0 100.0
Newly diagnosed without treatment Newly diagnosed with treatment Persistence or recurrence Remission None Chemotherapy Radiotherapy Concurrent chemoradiation
0 25.0 50.0 75.0 100.0
Newly diagnosed without treatment Newly diagnosed with treatment Persistence or recurrence Remission None Chemotherapy Radiotherapy Concurrent chemoradiation
0 25.0 50.0 75.0 100.0
Newly diagnosed without treatment Newly diagnosed with treatment Persistence or recurrence Remission None Chemotherapy Radiotherapy Concurrent chemoradiation
+XPSKULHV 6( &RPPRQ SURPRWHU YDULDQW LQ
F\FORR[\JHQDVH UHSUHVVHV JHQH H[SUHVVLRQ HYLGHQFH RI
UROH LQ DFXWHSKDVH LQÁDPPDWRU\ UHVSRQVH Arterioscler 7KURPE9DVF%LRO, 22
3ULFH 6- *UHDYHV '5 :DWNLQV + ,GHQWLÀFDWLRQ RI
QRYHO IXQFWLRQDO JHQHWLF YDULDQWV LQ WKH KXPDQ PDWUL[
PHWDOORSURWHLQDVH JHQH UROH RI 6S LQ DOOHOHVSHFLÀF
WUDQVFULSWLRQDOUHJXODWLRQ-%LRO&KHP, , 7549-58.
5XXG - 1LOVVRQ$ 5XXG / :DQJ : HW DO &DQFHU
LQGXFHG DQRUH[LD LQ WXPRUEHDULQJ PLFH LV GHSHQGHQW RQ
F\FORR[\JHQDVH%UDLQ%HKDY,PPXQ, 29
6DQJHU ) 1LFNOHQ 6 &RXOVRQ$5 '1$ VHTXHQFLQJ
ZLWKFKDLQWHUPLQDWLQJLQKLELWRUV3URF1DWO$FDG6FL86
A,
6KDKHGL . /LQGVWURP 6 =KHQJ 6/ HW DO *HQHWLF
YDULDWLRQLQWKHCOX-2JHQHDQGWKHDVVRFLDWLRQZLWKSURVWDWH
cancer risk. Int J Cancer, 119
6LLURQHQ 3 5LVWLPDNL$ 1RUGOLQJ 6 ([SUHVVLRQ RI
COX-2 LV LQFUHDVHG ZLWK DJH LQ SDSLOODU\ WK\URLG FDQFHU
+LVWRSDWKRORJ\, 44, 490-7.
6LYXOD$7DOYHQVDDUL0DWWLOD$/XQGLQ-$VVRFLDWLRQ
RI F\FORR[\JHQDVH DQG PDWUL[ PHWDOORSURWHLQDVH
H[SUHVVLRQ LQ KXPDQ EUHDVW FDQFHU Breast Cancer Res 7UHDW, 89
6RQJ):DQJ/+XDQJ<HWDO0L5XSUHJXODWLRQ
LQGXFHGE\SURPRWHU]RQHKLVWRQHDFHW\ODWLRQLVDVVRFLDWHG
ZLWK FKHPRUHVLVWDQFH WR JHPFLWDELQH DQG HQKDQFHG
PDOLJQDQF\RISDQFUHDWLFFDQFHUFHOOVAsian Pac J Cancer Prev, 14
7KLHO$1DUNR.+HLQRQHQ0+HPPHV$7RPDVHWWR&5LR
0& 5LVWLPlNL$ ,QKLELWLRQ RI F\FORR[\JHQDVH
FDXVHV UHJUHVVLRQ RI JDVWULF DGHQRPDV LQ WUHIRLO IDFWRU
GHÀFLHQWPLFHInt J Cancer, 131
7VDWVDQLV&$QGURXOLGDNL$9HQLKDNL00DUJLRULV$1
6LJQDOOLQJ QHWZRUNV UHJXODWLQJ F\FORR[\JHQDVH Int J
%LRFKHP&HOO%LRO, 38
7VXMLL 0 .DZDQR 6 'X%RLV 51 &\FORR[\JHQDVH
expression in human colon cancer cells increases metastatic potential.3URF1DWO$FDG6FL86$, 94
:DQJ;)X;%URZQ3'&ULPPLQ0- )RIIPDQ50
0DWUL[ PHWDOORSURWHLQDVH LQKLELWRU %% EDWLPDVWDW LQKLELWVKXPDQFRORQWXPRUJURZWKDQGVSUHDGLQDSDWLHQW
like orthotopic model in a nude mice. Cancer Res, 54,
:DQJ''XERLV513URVWDJODQGLQVDQGFDQFHU Gut, 55
:DVWVRQ6$0RUULV705RELQVRQ*HWDO,QKLELWLRQRI
RUJDQLQYDVLRQE\WKHPDWUL[PHWDOORSURWHLQDVHLQKLELWRU%%
EDWLPDVWDWLQWZRKXPDQFRORQFDUFLQRPDPHWDVWDVLV
models. Cancer Res, 55
:DVWRQ6$0RUULV703DUVRQV6/6WHHOH5-&%URZQ3'
7KHUDSHXWLF HIIHFW RI PDWUL[ PHWDOORSURWHLQDVH
LQKLELWRUEDWLPDVWDWLQDKXPDQFRORUHFWDOFDQFHUDVFLWHV
model. Br J Cancer,
:X +& &KDQJ &+ .H +/ HW DO $VVRFLDWLRQ RI
F\FORR[\JHQDVH SRO\PRUSKLF JHQRW\SHV ZLWK SURVWDWH
FDQFHULQ7DLZDQAnticancer Res, 31
:X&<:DQJ&-7VHQJ&&+HOLFREDFWHUS\ORULSURPRWH
JDVWULFFDQFHUFHOOVLQYDVLRQWKURXJKD1)NDSSD%DQGCOX- 2-mediated pathway, World J Gastroenterol, 11
;X ( /DL 0 /Y % HW DO $ VLQJOH QXFOHRWLGH
polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer. %LRFKHP%LRSK\V5HV
&RPPXQ, 324
=HUYRV (( 1RUPDQ -* *RZHU:5 )UDQ] 0* 5RVHPXUJ\
$60DWUL[PHWDOORSURWHLQDVHLQKLELWLRQDWWHQXDWHV
KXPDQ SDQFUHDWLF FDQFHU JURZWK LQ YLWUR DQG GHFUHDVHV
PRUWDOLW\DQGWXPRULJHQHVLVLQYLYRJ Sur Res, 69
=KDQJ;0LDR;7DQ:HWDO,GHQWLÀFDWLRQRIIXQFWLRQDO
JHQHWLFYDULDQWVLQF\FORR[\JHQDVHDQGWKHLUDVVRFLDWLRQ
ZLWK ULVN RI HVRSKDJHDO FDQFHU Gastroenterology, 129,
=KDR)=KX++XDQJ0<L&+XDQJ<7KH*!
&SRO\PRUSKLVPLQWKHF\FORR[\JHQDVHJHQHDQGJDVWULF
FDQFHUULVNDQXSGDWHE\PHWDDQDO\VLVAsian Pac J Cancer Prev, 15